Is recombinant Human Nerve Growth Factor an effective treatment for Stage 1 Neurotrophic Keratopathy? Dr. Drew Carey discusses this with Dr. Pedram Hamrah author of Ophthalmology’s “Efficacy of Recombinant Human Nerve Growth Factor in Stage 1 Neurotrophic Keratopathy.”
VidClip of visualization of the peripheral retina during ROP screening using scleral depression and OCT. En face views and cross-sectional scans are shown simultaneously in real time. The scleral depressor, seen prior to image acquisition, provides indentation throughout this process and facilitates view of peripheral vasculature. This video demonstrates the rapid acquisition time of the investigational portable handheld OCT system.